Search

everythinglearnresearchcommunity

for

Search:↓

Understanding and manipulating epigenetic changes can potentially lead to human organ regeneration therapies, but more research is needed to improve these methods and minimize risks.

Possible link between androgens and COVID-19 severity; more research needed.

Quinoline alkaloids from Cinchona may help treat cancer, diabetes, fungal infections, and promote hair growth.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Pantethine may boost the immune system's ability to fight sarcoma.

Long COVID causes various long-term health issues and needs better awareness and treatment.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Extracellular vesicles show promise for wound healing, but more research is needed to improve their stability and production.

The new delivery system improved hair growth in alopecia treatment.

Finasteride may lower cholesterol and slow heart disease progression.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Siddha medicine uses herbs and minerals to safely treat skin diseases like psoriasis and eczema.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Melatonin, usually known for sleep regulation, also has antioxidant properties that can protect skin, stimulate hair growth, and improve skin conditions, with topical application being more effective than oral use.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Melatonin, a hormone, can help protect skin from aging by reducing stress, inflammation, and damage, and may also help treat hair loss in women.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

High mTORC1 activity slows hair growth and causes it to lose color.

Four specific genes are linked to keloid formation and could be potential treatment targets.